EGFR and cancer: Similarly, Phill et al. [43] decorated the nanoparticles of ELP-modified Illama heavy-chain antibody fragment (VHH), targeting the epidermal growth factor receptor (EGFR) overexpressed in various cancers with the photosensitizer IRDye 700 by conjugation and determined its cell-killing efficiency.